Patrick Yang, PhD
Co-Founder/ Executive Vice Chairman / National Resilience, Inc.
Patrick Yang is the veteran of biotechnology in the United States and an academician of the Industrial Technology Research Institute. He used to be the President of Global Technical Operations of Roche Pharmaceuticals, the Executive Vice President of Genentech Biotechnology Company in the United States, and the Executive Vice President of Juno Therapeutics Cell Therapy Biotechnology Company in the United States. Known as "Chang Chung-mou of Taiwan's biotechnology industry". Before that, he served as vice president of Merck (Merck) pharmaceutical company; General Electric (GE) engineering manager. Currently director of Quanxin New Drug, founder/vice chairman of National Resilience, Inc., founder/chairman of Yushibo Biotechnology Co., Ltd., director of Taishan Investment Management Consulting Company, chairman of British Archigen Biotech, biotechnology consultant of the Executive Yuan Committee member and specially appointed expert, independent director of PharmaEssentia, director of Polaris Pharmaceuticals, director of Codexis, director of Amyris, director of Antheia and founding director of Sana Biotechnology Company in the United States.